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A healthy 15-year-old girl presented with multiple
progressive painful ulcers and atrophie blanche over
bilateral lower legs and feet for 4 months (Fig. 1A). Skin
biopsy revealed hyalinized vascular change and throm-
bosis of the upper reticular dermal vessels (Fig. 1B).
Direct immunofluorescence study revealed perivascular
fibrinogen deposition. A diagnosis of livedo vasculitis was
made.
Warfarin (1.65 mg/day) was administered to control the
disease activity. However, clinical symptoms and signs did
not improve but exacerbate with extensive skin necrosis 2
weeks later (Fig. 1C). Histopathologic examination of the
necrotic area showed diffuse thrombotic vasculopathies in
the upper dermis (Fig. 1D). Prothrombin time was pro-
longed to 14.8 seconds (control: 10.7 seconds) and the
international normalized ratio was 1.47. Partial thrombo-
plastin time was 28.8 seconds (control: 27.1 seconds).
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range: 55%e130%) was identified without evidence for
a deficiency of protein C (105% activity, normal range: 80%e
132%). Antithrombin III, fibrinogen, clotting factors (VIII, IX,
XI), and von Willebrand factor were all within normal
ranges. Serum homocysteine was not elevated and cry-
oglobulin was negative. Survey of the autoimmune anti-
bodies showed negative results. Serum immunoglobulin G,
immunoglobulin A, immunoglobulin M, complement 3,
complement 4, C-reactive protein, complete blood count,
erythrocyte sedimentation rate, liver function, renal
function, electrolytes, electrocardiography, stool, and
urine examinations were all normal. Parents and siblings of
the patient were tested for serum protein C and protein S,
which turned out to be normal.
Warfarin was discontinued and the patient was treated
by subcutaneous injections of enoxaparin sodium (60 mg/
day) for 2 weeks. Pain improved without progression of
skin necrosis and prothrombin time (10.7 seconds, control:
11.3 seconds), Dedimer (0.36 mg/L), and serum protein S
level (74% activity) all became normal. The skin lesions
gradually healed within 1 month.
Warfarin-induced skin necrosis is a rare complication
which affects 0.01%e0.1% of all patients treated with
oral anticoagulants.2 A number of cases have been re-
ported in association with congenital deficiency of
protein C or protein S.3 Some other cases are related to
acquired protein C and protein S deficiency.4 Isolated& Formosan Medical Association. All rights reserved.
Figure 1 (A) Painful crusted ulcers and atrophie blanche on the patient’s left ankle and foot. Similar lesions could be observed in
the opposite lower extremity. (B) Hyalinization and thrombosis of the upper reticular dermal vessels. Minimal perivascular
lymphocytic infiltrate was noted (hematoxylin and eosin, 100). (C) Extensive necrotic areas were noted on the patient’s left
dorsal foot 2 weeks later after administration of warfarin. The patient’s right lower leg and foot also showed similar skin necrosis.
(D) Thrombotic vasculopathy with fibrinoid necrosis of the vascular wall and marked red blood cell extravasation in the upper
dermis. Prominent papillary dermal edema, interstitial, and perivascular lymphocytic infiltration could also be noted (hematoxylin
and eosin, 100).
Warfarin-induced protein S deficiency 759acquired protein S deficiency has never been reported.
The pathomechanism of this adverse cutaneous reaction
is not fully understood and had been mainly explained by
the rapid decline of serum protein C level relative to
coagulation factors II, IX, and X in the initial stages of
warfarin action.5 Here, we first report that warfarin can
selectively induce protein S deficiency and low-
molecular-weight heparin can be used to prevent
further thrombosis. We recommend that close monitoring
of serum protein S and protein C levels within the first 2
weeks in patients under warfarin treatment is warranted.
Clinicians should be alert to this rare, but potentially
serious, complication whenever suspicious skin lesions
occur. Early diagnosis and drug withdrawal can be limb or
life saving.References
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